Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanjing Ma

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemical and Biophysical Research Communications|June 4, 2025
CDKL3, a versatile kinase with increasing recognitionLanjing Ma, Haijiao Zhang, Zhongqiu Pang, et al.
Protein & Cell|May 5, 2018
Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectivesLijuan Sun, Lanjing Ma, Yubo Ma, et al.
Oncology Reports|January 13, 2018
Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathwayQianqian Tang, Yunfei Wang, Lanjing Ma, et al.
Veterinary Sciences|January 28, 2026
Luteolin Inhibits Bovine Viral Diarrhea Virus Replication by Disrupting Viral Internalization and Replication and Interfering with the NF-κB/STAT3-NLRP3 Inflammasome PathwayDongjie Cai, Qing Liu, Zifan Shen, et al.
Infection and Drug Resistance|October 28, 2024
The Endocytosis Adaptor Sla1 Facilitates Drug Susceptibility and Fungal Pathogenesis Through Sla1-Efg1 Regulating System in <i>Candida albicans</i>Chenhao Suo, Yiru Gao, Sheng Yang, et al.
Theranostics|February 28, 2019
<i>Fto</i> Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut MicrobiotaLijuan Sun, Lanjing Ma, Haohao Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 17, 2022
Aberrant Cholesterol Metabolism and Wnt/β-Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer GrowthShaoqin Zheng, Jiahui Lin, Zhongqiu Pang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Clear cell renal carcinoma essentially requires CDKL3 for oncogenesisLanjing Ma, Zhongqiu Pang, Haijiao Zhang, et al.
The Journal of Clinical Investigation|July 4, 2024
CDKL3 is a targetable regulator of cell cycle progression in cancersHaijiao Zhang, Jiahui Lin, Shaoqin Zheng, et al.
Life Science Alliance|October 21, 2022
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|June 4, 2025
CDKL3, a versatile kinase with increasing recognitionLanjing Ma, Haijiao Zhang, Zhongqiu Pang, et al.
Protein & Cell|May 5, 2018
Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectivesLijuan Sun, Lanjing Ma, Yubo Ma, et al.
Oncology Reports|January 13, 2018
Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathwayQianqian Tang, Yunfei Wang, Lanjing Ma, et al.
Veterinary Sciences|January 28, 2026
Luteolin Inhibits Bovine Viral Diarrhea Virus Replication by Disrupting Viral Internalization and Replication and Interfering with the NF-κB/STAT3-NLRP3 Inflammasome PathwayDongjie Cai, Qing Liu, Zifan Shen, et al.
Infection and Drug Resistance|October 28, 2024
The Endocytosis Adaptor Sla1 Facilitates Drug Susceptibility and Fungal Pathogenesis Through Sla1-Efg1 Regulating System in <i>Candida albicans</i>Chenhao Suo, Yiru Gao, Sheng Yang, et al.
Theranostics|February 28, 2019
<i>Fto</i> Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut MicrobiotaLijuan Sun, Lanjing Ma, Haohao Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 17, 2022
Aberrant Cholesterol Metabolism and Wnt/β-Catenin Signaling Coalesce via Frizzled5 in Supporting Cancer GrowthShaoqin Zheng, Jiahui Lin, Zhongqiu Pang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2025
Clear cell renal carcinoma essentially requires CDKL3 for oncogenesisLanjing Ma, Zhongqiu Pang, Haijiao Zhang, et al.
The Journal of Clinical Investigation|July 4, 2024
CDKL3 is a targetable regulator of cell cycle progression in cancersHaijiao Zhang, Jiahui Lin, Shaoqin Zheng, et al.
Life Science Alliance|October 21, 2022
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
Pageof 2